Header Artwork
Header Artwork



Evaluating Persistent or Residual Antimicrobial Efficacy of Topically Applied Products in a Clinical Trial

Published Date: November 2, 2022

Topically applied antimicrobial products are an important tool to help limit the spread of microorganisms and diseases. This webinar will introduce methods that are currently used for evaluating the immediate, persistent, and residual antimicrobial effects of topically applied antimicrobial products using simulated-use clinical trial testing.

You will learn by attending this webinar:

  • Common terminology used when evaluating topically applied antimicrobial products
  • Sampling procedures used to assay microbial flora from the skin
  • Numerous test methods used to evaluate efficacy of topically applied products using a simulated-use clinical trial study

Christopher Beausoleil, CCRP

Department Scientist (Clinical)

Christopher Beausoleil has worked at Nelson Labs Bozeman (formerly known as BioScience Laboratories, Inc.) since 1994 in the laboratories and has been involved in all phases of testing. He has extensive experience in evaluating the efficacy and safety of products using standard FDA methods and customized protocols.

Complete the form below to access the webinar.